Sponsor:
University of Utah
Code:
NCT07032584
Conditions
Prostate Cancer
Metastatic Prostate Cancer
Androgen Deprivation Therapy
Eligibility Criteria
Sex: Male
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Telerehabilitation Intervention
Brief summary:
Conditions
Prostate Cancer
Metastatic Prostate Cancer
Androgen Deprivation Therapy
Study ID
NCT07032584
Start date
May 27, 2025
Status verified date
Jul, 2025
Completion date
Dec, 2029
Anticipated
Primary completion date
Dec, 2029
Anticipated
Eligibility Criteria
Sex: Male
Age: 21+
Healthy Volunteers: Not accepted
Enrollment
74 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Telerehabilitation Intervention
other: Best Available Care
Interventions
Telerehabilitation Intervention
Primary outcome measure
Central contacts
Locations
University of Utah Huntsman Cancer Institute
Recruiting
Salt Lake City, Utah, United States, 84112
Contacts
Sponsor
University of Utah
Last update posted
Aug 1, 2025
Last verified
Jul, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Utah on 2025-08-01.